edoc

Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma : results of a phase I study

Dufour, Jean-François and Hoppe, Hanno and Heim, Markus H. and Helbling, Beat and Maurhofer, Olivier and Szucs-Farkas, Zsolt and Kickuth, Ralph and Borner, Markus and Candinas, Daniel and Saar, Bettina. (2010) Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma : results of a phase I study. The oncologist, Vol. 15, H. 11. pp. 1198-1204.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6006784

Downloads: Statistics Overview

Abstract

It is unknown whether sorafenib can be combined with transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma. This study assesses the safety and tolerability of a continuous regimen of sorafenib combined with TACE.
Faculties and Departments:03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Hepatology Laboratory (Heim)
UniBasel Contributors:Heim, Markus H.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:AlphaMed Press
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:01 Feb 2013 08:46
Deposited On:01 Feb 2013 08:43

Repository Staff Only: item control page